Sandbox vidit2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 27: | Line 27: | ||
===Complication Specific Management=== | ===Complication Specific Management=== | ||
{{familytree/start |style=font-size:85%; line-height: 120%; | summary=PE diagnosis Algorithm.}} | {{familytree/start |style=font-size:85%; line-height: 120%; | summary=PE diagnosis Algorithm.}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Complication specific management}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | {{familytree | | |,|-|-|-|-|-|-|v|-|-|-|-|-|-|v|-|-|-|-|-|-|-|+|-|-|-|-|-|-|v|-|-|-|-|-|-|v|-|-|-|-|-|-|.| |}} | ||
{{familytree | | | | | | | | | | | | | {{familytree | | |!| | | | | | |!| | | | | | |!| | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | |!| |}} | ||
{{familytree | | | | | | | | | | | | {{familytree | | B01 | | | | | B02 | | | | | B03 | | | | | | B04 | | | | | B05 | | | | | B06 | | | | | B07 | | | |B01=Ascites|B02=Cerebral edema & increased ICP|B03=Coagulopathy|B04=Hemodynamic instability|B05=Hepatic encephalopathy|B06=Metabolic disturbances|B07=Renal failure}} | ||
{{familytree | | | | | | | | | | | | | {{familytree | | |!| | | | | | |!| | | | | | |!| | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | {{familytree | | C01 | | | | | C02 | | | | | C03 | | | | | | C04 | | | | | C05 | | | | | C06 | | | | | C07 |C01=Therapeutic paracentesis w/ 25% albumin<BR><br> <3 mEq/Kg of Na daily<BR><br> Lasix & aldactone|C02=ICP >25 mmHg|C03=+ Bleeding or prior to surgery|C04=Colloid, dextrose in crystalloid (if hypoglycemic) & 1/2 NS w/ 75 mg/L HCO3 (if acidotic)<BR><br> Norepinephrine±vasopressin<BR><br> Hydrocortisone|C05=Grade|C06=Rx acidosis, alkalosis, hypophosphatemia, hypomagnesemia, hypokalemia or hypoglycemia accordingly|C07=Continuous venovenous hemodialysis}} | ||
{{familytree | | | | | | | | | | | | | | | | |!| | | {{familytree | | | | | | | | | |!| | | | | | |!| | | | | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | {{familytree | | | | | | | | | D01 | | | | | D02 | | | | | | D03 | | | | | D04 | | | | | D05 | | | | | | | | | | | | | | |D01=SpO2|D02=Platelet transfusion (if ≤50,000/mm2)<BR><br> FFP /+ rFVIIa (if INR≥1.5)|D03=I|D04=II|D05=III/IV}} | ||
{{familytree | {{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | {{familytree | | E01 | | | | | | | | | | | | E02 | | | | | | E03 | | | | | E04 | | | | | E05 | | | | | | | | | | | | | | | | |E01= <80 |E02= >80 |E03= 2nd hourly monitoring in quiet environment in high dependency ward|E04=ICU management<BR><br> Stat CT to R/O ICH<BR><br> Short acting BZD<BR><br> Lactulose|E05=ICU management<BR><br> Intubation & mechanical ventilation<BR><br> Propofol<BR><br> Elevate head end to 30°<BR><br> Quiet environment monitoring for CVP, hemodynamic & renal parameters, serum electrolytes, acid base status & neurological status}} | ||
{{familytree | | | | | | | | | {{familytree | | |!| | | | | | | | | | | | | |!| | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | F01 |-|-|-|-| F02 |-|-|-|-| F03 | | | | | | F04 | | | | | | | | | | | | | | | | | | | | | | |F01=20% mannitol|F02=No improvement|F03=Hyperventillation|F04=Worsening}} | ||
{{familytree | | | | | | | | {{familytree | | |!| | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | {{familytree | | G01 | | | | | | | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | | | | | | | | | | |G01=3% NS|G02=Transfer to ICU}} | ||
{{familytree | {{familytree | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | H01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |H01=Reduce core temperature to 32°-34° (monitor for arrhythmias)}} | ||
{{familytree | {{familytree | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | I01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |I01=Thiopental 125 mg i.v bolus}} | ||
{{familytree | {{familytree | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | J01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |J01=Improvement or refractory}} | ||
{{familytree | {{familytree | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | K01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |K01=Transplantation}} | ||
{{familytree/end}} | {{familytree/end}} |
Revision as of 18:59, 9 December 2013
General Management
Continuous monitoring under quite environment w/ preventive treatment strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cerebral edema & increased ICP | Coagulopathy | Drugs | GI bleeding | Hemodynamic instability | Hepatic encephalopathy | Infections | Metabolic disturbances | NAC | Nutritional deficiency | Renal failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Monitor ICP, CPP & cerebral oxygenation *Elevate head end to 30° *Monitor fluid status *3% NS *Avoid NGT and suction | *Platelet count & coagulation profile (12th hourly) *Inj. Vit. K *Cryoprecipitate | *Discontinue medications *Avoid nephrotoxic & hepatotoxic drugs | *Ranitidine | *Monitor CVP w/ central venous catheter | *Frequent monitoring of mental status | *CBC (12th hourly) *CXR; sputum, blood & urine cultures (daily) *Cefotaxime, meropenem, fluconazole or vancomycin | *Serum BCH, ABG, lactate (12th hourly) *Serum glucose (2nd hourly) | *NAC (i.v × 2d then P.O.) | *Eternal feeding *Parental feeding | *Urinary I/O | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Etiology Specific Management
Etiology specific management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*H/o acetaminophen intake *Consider if no H/o but elevated aminotransferase (>3500 IU/L) | *Jaundice, coagulopathy, thrombocytopenia ± hypoglycemia *Hypertension & proteinuria *+ Steatosis during liver imaging or biopsy | *Elevated aminotransferase responding to fluid resuscitation *Associated renal dysfunction & muscle necrosis | *+ Serum autoantibodies *+ Liver biopsy | *Abdominal pain, ascites and hepatomegaly *+ Liver imaging (CT/MRV/venogram/doppler USG) | *H/o hepatotoxic drug intake (<6m) *Unlikely if H/o intake >1 or 2 years | *Massive hepatomegaly *+ Liver imaging & biopsy | *H/o mushroom intake *Suspect if no H/o but severe GI Sx (NVD) | *+ Hepatitis serology *+ Liver biopsy for HSV | *Serum bilirubin >20g/dL, bilirubin:alkaline phosphatase >2.0, low serum ceruloplasmin, elevated serum & urine copper, + KF ring, + liver biopsy | Etiology undetermined | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acetaminophen toxicity | Acute fatty liver of pregnancy/HELLP | Acute ischemic injury | Autoimmune | Budd-Chiari | Drug induced | Malignant infiltration | Mushroom poisoning | Viral | Wilson's disease | Intermediate etiology | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Activated charcoal *NAC | *Deliver immediately | *Manage the cause of ischemia | *Prednisolone *Transplantation | *Transplantation | *Discontinue all possible medications except essential drugs | *Supportive Rx | *Activated charcoal & gastric lavage *Penicillin G or Silibinin *Fluid resuscitation | *Supportive Rx *Lamivudine or adefovir *Acyclovir | *Dialysis or hemofiltration or plasmapheresis or plasma exchange *Transplantation | *Incomplete drug or toxin intake H/O *Transjugular biopsy to R/O mailgnancy, Wilson's disease, autoimmune hepatitis or viral hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Complication Specific Management
Complication specific management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ascites | Cerebral edema & increased ICP | Coagulopathy | Hemodynamic instability | Hepatic encephalopathy | Metabolic disturbances | Renal failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Therapeutic paracentesis w/ 25% albumin <3 mEq/Kg of Na daily Lasix & aldactone | ICP >25 mmHg | + Bleeding or prior to surgery | Colloid, dextrose in crystalloid (if hypoglycemic) & 1/2 NS w/ 75 mg/L HCO3 (if acidotic) Norepinephrine±vasopressin Hydrocortisone | Grade | Rx acidosis, alkalosis, hypophosphatemia, hypomagnesemia, hypokalemia or hypoglycemia accordingly | Continuous venovenous hemodialysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SpO2 | Platelet transfusion (if ≤50,000/mm2) FFP /+ rFVIIa (if INR≥1.5) | I | II | III/IV | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
<80 | >80 | 2nd hourly monitoring in quiet environment in high dependency ward | ICU management Stat CT to R/O ICH Short acting BZD Lactulose | ICU management Intubation & mechanical ventilation Propofol Elevate head end to 30° Quiet environment monitoring for CVP, hemodynamic & renal parameters, serum electrolytes, acid base status & neurological status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20% mannitol | No improvement | Hyperventillation | Worsening | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3% NS | Transfer to ICU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reduce core temperature to 32°-34° (monitor for arrhythmias) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thiopental 125 mg i.v bolus | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Improvement or refractory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplantation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||